MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-22.69%
↑ 95% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-446.96%
Historical baseline
PeriodValue
2024-22.69%
202319.13%
2022-307.28%
2021-1923.97%
20200.00%